You are here

Novartis

Novartis Builds Case for Earlier Prostate Cancer Treatment with Phase III Data

BioSpace

Tue, 10/24/23 - 09:54 am

prostate cancer

radiopharmaceuticals

Novartis expats detail their health-tech spinoff DatosX

Medical Marketing and Media

Wed, 10/11/23 - 11:44 pm

Novartis cuts depression study, nearly erasing $210M Cadent acquisition from pipeline

Fierce Biotech

Tue, 10/10/23 - 11:36 am

Cadent Therapeutics

major depressive disorder

Novartis-backed AstronauTx heads off for Alzheimer's mission with $61M series A

Fierce Biotech

Mon, 10/9/23 - 11:12 am

Alzheimer's disease

Novartis Wins FDA Approval for Intravenous Cosentyx Formulation

BioSpace

Mon, 10/9/23 - 10:14 am

ankylosing spondylitis

psoriatic arthritis

non-radiographic axial spondyloarthritis

Novartis' Sandoz dips on debut after lower than expected valuation

Reuters

Wed, 10/4/23 - 09:43 am

Novartis eyes accelerated FDA approval for iptacopan across multiple indications

Clinical Trials Arena

Mon, 10/2/23 - 10:14 am

clinical trials

IgA nephropathy

Adlai Nortye IPO gives old Novartis cancer drug new life

BioPharma Dive

Fri, 09/29/23 - 10:22 am

head and neck cancer

Novartis confirms Sandoz spin-off for October 4, 2023

Reuters

Mon, 09/25/23 - 07:45 pm

Novartis eyes first-line use of Lutathera after trial win

Pharmaphorum

Mon, 09/25/23 - 11:41 am

clinical trials

neuroendocrine tumors

FDA Regulatory Gauntlet Isn’t Getting Any Easier, Just Ask These Companies

BioSpace

Sun, 09/24/23 - 08:52 pm

ARS Pharmaceuticals

Novartis hit with another serious drug marketing breach, this time for multiple sclerosis therapy Mayzent

Fierce Pharma

Thu, 09/21/23 - 10:36 am

pharma marketing

BeiGene to go solo with cancer drug after Novartis deal termination

Yahoo/Reuters

Tue, 09/19/23 - 10:30 am

Bausch + Lomb seeks funding for eye drug acquisition from Novartis

BioPharma Dive

Wed, 09/13/23 - 11:32 am

Novartis recalls Sandimmune oral solution due to crystal formation

Pharmaceutical Technology

Tue, 09/12/23 - 07:14 pm

product recalls

organ transplants

Novartis Drops Eye Disease Gene Therapy from $800M Gyroscope Acquisition

BioSpace

Mon, 09/11/23 - 12:28 pm

geographic atrophy

Gyroscope Therapeutics

Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts

Fierce Pharma

Fri, 09/8/23 - 10:29 am

Novartis names new board member after international boss steps down

Reuters

Wed, 09/6/23 - 10:06 am

Marie-France Tschudin

Novartis files suit against IRA after blockbuster Entresto makes CMS' price negotiations list

Fierce Pharma

Tue, 09/5/23 - 08:54 pm

Inflation Reduction Act

Pages